Gem Aromatics Ltd

Gem Aromatics Limited submitted a certificate to the BSE Limited and National Stock Exchange of India Limited on October 6, 2026, confirming no Demat/Remat requests were processed for the quarter ended September 30, 2026, as per Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, with KFin Technologies Limited acting as the Registrar and Share Transfer Agent.

Gem Aromatics Limited informed the BSE Limited and National Stock Exchange of India Limited that the trading window for dealing in the company's securities will be closed for designated persons and their immediate relatives from October 1, 2026, until 48 hours after the declaration of the unaudited financial results (standalone and consolidated) for the quarter and half year ending September 30, 2026.

Gem Aromatics Limited announced that its Executive Committee of the Board approved the conversion of a pre-existing inter-company loan into equity shares of its wholly owned subsidiary, Krystal Ingredients Private Limited, which reported a turnover of Rs 323.296 million and a net worth of Rs 598.643 million for the fiscal year ending March 31, 2026. The transaction, which is considered an arm’s length related party transaction, will not involve any fresh capital infusion and is expected to be completed within one month.

Gem Aromatics Ltd share price dropped 5.90% to Rs 170.55 after the company's net profit tumbled by 879.21% to Rs 7.87 crore, while revenue from operations slipped 10.47% to Rs 98.85 crore in Q2FY26 over Q1FY26. The market capitalization of Specialty Chemicals industry group stocks on BSE stood at Rs 5.11 lakh crore, improving 14.40%. It has eased by 0.10% over last one week and rose by 12.48% in last one month while the market capitalization of Gem Aromatics Ltd has slipped by 6.60% and 10.35% in the same period respectively. Profit before tax (PBT) of Gem Aromatics Ltd stood at Rs 8.54 crore in Q2 FY26, crashing by 179.15% year-on-year, and nosediving by 311.91% quarter-on-quarter. EBITDA came in at Rs 3 crore, tumbling by 76.82% YoY and tanking 79.56% sequentially. Total expenses posted a minor rise of 0.93% to Rs 104.67 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 99.04 crore, witnessing a sharp rise of 29.91% YoY, while employee benefits expense was at Rs 7.06 crore, jumping 14.61% YoY. For the TTM ended FY26, revenue from operations tumbled 27.28% to Rs 366.47 crore, while net profit tanked by 97.32% to Rs 1.43 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 10134% to Rs 39.85 crore, and PBT collapsed by 91.45% to Rs 6.36 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 29.6 crore in FY26, as against Rs 24.92 crore in FY25. Gem Aromatics Ltd nosedived by 46.55% in last one year, underperforming the benchmark BSE Sensex which has softened by 2.83% during the same period.

Gem Aromatics Limited will hold a meeting of its Board of Directors on August 13, 2026, to consider and approve the standalone and consolidated unaudited financial results for the quarter ended June 30, 2026, according to a regulatory filing. The trading window for the company's securities will be closed for designated persons and their immediate relatives from July 1, 2026, until 48 hours after the declaration of the unaudited financial results.

Gem Aromatics announced that the 29th Annual General Meeting(AGM) of the company will be held on 19 August 2026.

Net profit of Gem Aromatics declined 96.34% to Rs 1.01 crore in the quarter ended March 2026 as against Rs 27.60 crore during the previous quarter ended March 2025. Sales declined 45.40% to Rs 110.41 crore in the quarter ended March 2026 as against Rs 202.22 crore during the previous quarter ended March 2025. For the full year,net profit declined 97.32% to Rs 1.43 crore in the year ended March 2026 as against Rs 53.38 crore during the previous year ended March 2025. Sales declined 27.28% to Rs 366.47 crore in the year ended March 2026 as against Rs 503.95 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales110.41202.22 -45 366.47503.95 -27 OPM %14.2322.68 -11.1217.55 - PBDT13.0442.00 -69 28.9581.73 -65 PBT4.0340.08 -90 6.3674.38 -91 NP1.0127.60 -96 1.4353.38 -97 Powered by Capital Market - Live

Gem Aromatics will hold a meeting of the Board of Directors of the Company on 21 May 2026.

The company stated that, with the improving international business environment following the proposed FTA with the European Union and tariff reductions by the United States, have led to a revival in export demand. Orders that were previously delayed due to higher US tariffs on Indian goods are now gradually resuming, with increasing customer inquiries translating into confirmed business. In line with this positive momentum, the company has received multiple export orders aggregating to $1 million from customers across the USA and Europe. Additionally, the manufacturing of Catalyst for MEHQ is progressing in line with planned timelines, and expected to be completed by Q4FY26. Yash Vipul Parekh, managing director & CEO, stated: 'The new export orders from the USA and Europe reflect an improving global trade environment, supported by the easing of tariff related headwinds. With previously deferred demand now gradually returning, we are witnessing a steady increase in customer inquiries, many of which are progressively converting into firm business commitments. This trend provides visibility and a positive outlook for the upcoming quarters. On the manufacturing front, the commencement of additional products manufacturing at our greenfield facility in Dahej under Krystal Ingredients Private Limited is an important step forward in our growth strategy. New products such as GEM Cool 5 and Safranal will further diversify our product portfolio and enhance our offerings to clients across markets. We are well-positioned to serve our growing domestic and international customer base and remain committed to creating long-term value for all our stakeholders.' GEM Aromatics manufactures specialty ingredients, essential oils, aroma chemicals, and value-added derivatives. The company partners with several leading brands, including Colgate-Palmolive, Dabur, Patanjali, SH Kelkar, Symrise, and others. Its products cater to industries including oral care, cosmetics, pharmaceuticals, nutraceuticals, wellness, and personal care, serving over 225 domestic and 44 global customers across 18 countries. The company reported consolidated net loss of Rs 4.99 crore in Q3 FY26 compared with net profit of Rs 7.46 crore in Q3 FY25. Net sales declined 18.5% YoY to Rs 78.90 crore in Q3 FY26.Powered by Capital Market - Live

Net loss of Gem Aromatics reported to Rs 4.99 crore in the quarter ended December 2025 as against net profit of Rs 7.46 crore during the previous quarter ended December 2024. Sales declined 18.53% to Rs 78.90 crore in the quarter ended December 2025 as against Rs 96.84 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales78.9096.84 -19 OPM %8.9013.46 - PBDT2.7811.31 -75 PBT-5.939.42 PL NP-4.997.46 PL Powered by Capital Market - Live